Virtual Reality-Reward Training for Anhedonia
VR-RT
1 other identifier
interventional
59
1 country
1
Brief Summary
The purpose of this study is to compare the effects of Virtual Reality-Reward Training (VR-RT) with an active control condition, Virtual Reality-Memory Training (VR-MT), on positive affect and other clinical symptoms. VR-Reward Training is a novel intervention aimed at enhancing savoring of positive experiences among individuals with depression and low positive affect through guided imaginal recounting following immersion in positive VR experiences. Target enrollment is 80 male and female participants with low positive affect, depression, and impaired functioning, who are at least 18 years old, who will be randomly assigned to 7 weeks of either Virtual Reality-Reward Training (VR-RT) or Virtual Reality-Memory Training (VR-MT). Participants will complete in-person VR sessions, laboratory assessments, self-report questionnaires as part of the study. The total length of participation is around 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_1
Started Sep 2022
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2022
CompletedFirst Posted
Study publicly available on registry
April 22, 2022
CompletedStudy Start
First participant enrolled
September 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2025
CompletedApril 4, 2025
May 1, 2024
2.5 years
March 16, 2022
April 1, 2025
Conditions
Outcome Measures
Primary Outcomes (3)
Depression, Anxiety, and Stress Scales (DASS-21)
Reported symptoms of depression (score range: 0-21), anxiety (score range: 0-21), and stress (score range: 0-21), higher scores indicate higher severity and frequency.
Change from baseline to follow-up (Week 12)
The Positive Affect and Negative Affect Schedule-Expanded Form (PANAS X) (General Dimensions Scales)
Change in reported positive affect (general dimensions scale positive affect) and negative affect (general dimension scale negative affect) (score range for each scale: 10-50, higher scores represent higher levels of positive affect or negative affect).
Change from baseline to follow-up (Week 12)
MASQ-AD 14 Item
Change in reported anhedonia (score range: 14-70), with higher scores indicating greater anhedonic symptom severity
Change from baseline to follow-up (Week 12)
Secondary Outcomes (6)
Behavioral Activation Scale (BAS)
Change from baseline to follow-up (Week 12)
Work and Social Functioning Scale (WSAS)
Change from baseline to follow-up (Week 12)
Positive and Negative Affective Schedule (PANAS)
Change from baseline to follow-up (Week 12)
Temporal Experience of Pleasure Scale (TEPS)
Change from baseline to follow-up (Week 12)
Effort Reward Trade-off Task
Change from baseline to follow-up (Week 12)
- +1 more secondary outcomes
Study Arms (2)
Virtual Reality-Reward Training (VR-RT)
EXPERIMENTAL7 sessions of positive VR immersion and positive memory specificity training exercises designed to savor rewarding features of immersion followed by memory specificity training exercises to savor rewarding features of autobiographical memory.
Virtual Reality-Memory Training (VR-MT)
ACTIVE COMPARATOR7 sessions of neutral VR immersion and neutral memory specificity training exercises, designed to train memory of objective non-emotional stimuli followed by memory exercises to neutral autobiographical memories.
Interventions
Participants will complete verbal recounting (present-tense, field perspective, positive details) and guided imaginal recounting of positive details for rewarding VR experiences and positive autobiographical memories.
Participants will complete verbal recounting (past-tense, observer perspective, objective details) and guided imaginal recounting of neutral details for neutral VR experiences and neutral autobiographical memories.
Eligibility Criteria
You may qualify if:
- At least 18 years old
- Fluent in written and spoken English
- Meet all of the following dimensional score cutoffs:
- Score on the DASS-21 depression subscale must be ≥ 11
- Score on the PANAS-P of 24 or lower
- Score on the SDS of ≥ 6
- Willingness to refrain from initiating other psychosocial treatments throughout the duration of the study
You may not qualify if:
- Lifetime history of bipolar disorder, psychosis, mental retardation, or organic brain damage
- Substance use disorder in the past 6 months
- Current use of psychotropic medications
- Currently pregnant or planning to become pregnant
- Self-reported frequent motion sickness
- Self-reported seizures within the last year and/or a diagnosis of epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, Los Angeles
Los Angeles, California, 90095, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michelle G Craske, Ph.D
University of California, Los Angeles
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 16, 2022
First Posted
April 22, 2022
Study Start
September 15, 2022
Primary Completion
March 14, 2025
Study Completion
March 14, 2025
Last Updated
April 4, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share